Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Cipla USA Inc., priced at $0.1519 per ML under NDC 69097090443. Its NADAC has been published 120 times since Nov 8, 2023.
Strength
6 mg/mL
Manufacturer
Cipla USA Inc.NDC
69097090443
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212858On Market Since
1/16/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 120 times since Nov 8, 2023, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1519 per ML |
|---|---|
| All-time high | $0.2776 (Jan 10, 2024) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1790 |
| 52-week low | $0.1519 |
| Median price | $0.1982 |
| Average price | $0.1981 |
| Largest weekly change | +38.5% (Dec 18, 2024) |
| Weeks tracked | 120 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Cipla USA Inc., is $0.1519 per ML (NDC 69097090443), effective Feb 18, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 40.8%. It has been tracked across 120 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Nov 8, 2023, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.2776 (Jan 10, 2024), with a median of $0.1982 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR 6 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 69097090443) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification